Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

There was no association between preoperative BMI and food security for either type of surgery (RYGB p = 0.54; SG p = 0.70, Tables 1 and 2).Descriptive statistics of patients who underwent Roux-en-Y gastric bypass by food security group (based on mRFEI)Patient characteristicAll patientsDesertSwampSecurep-value(N = 3424)(N = 900)(N = 885)(N = 1639)Age at surgery (years)46.5 [37.7, 55.6]46.7 [37.6, 55.9]46.0 [36.9, 55.7]46.7 [38.0, 55.3]0.47bGender0.69c Female2630 (76.8)699 (77.7)682 (77.1)1249 (76.2) Male794 (23.2)201 (22.3)203 (22.9)390 (23.8)Preop BMI (kg/m2)45.7 [41.1, 50.9]45.7 [41.5, 50.8]45.9 [41.0, 51.0]45.5 [41.0, 50.8]0.54bHispanic0.002c Yes105 (3.1)21 (2.3)45 (5.1)39 (2.4) No3276 (95.7)866 (96.2)829 (93.7)1581 (96.5) Unknown43 (1.3)13 (1.4)11 (1.2)19 (1.2)Race* < 0.001c Black734 (21.6)191 (21.3)228 (25.9)315 (19.3) White2581 (75.8)682 (76.2)619 (70.3)1280 (78.5) Unk/NR90 (2.6)22 (2.5)33 (3.8)35 (2.1)Baseline comorbiditiesDiabetes mellitus0.10c Yes, non-insulin795 (23.2)193 (21.4)205 (23.2)397 (24.2) Yes, insulin555 (16.2)138 (15.3)131 (14.8)286 (17.4) No2074 (60.6)569 (63.2)549 (62.0)956 (58.3)Severe COPD68 (2.0)16 (1.8)19 (2.1)33 (2.0)0.85cObstructive sleep apnea requiring CPAP/BiPAP2144 (62.6)589 (65.4)550 (62.1)1005 (61.3)0.11cGastroesophageal reflux disease requiring medication1235 (36.1)337 (37.4)309 (34.9)589 (35.9)0.53cHypertension requiring medication2075 (60.6)524 (58.2)533 (60.2)1018 (62.1)0.15cHyperlipidemia requiring medication1264 (36.9)303 (33.7)322 (36.4)639 (39.0)0.03cRenal insufficiency21 (0.61)6 (0.67)4 (0.45)11 (0.67)0.77cCurrently requiring or on dialysis19 (0.55)3 (0.33)10 (1.1)6 (0.37)0.04dBaseline laboratory valuesPreop Albumin* (g/dL)4.3 [4.1, 4.5]4.3 [4.1, 4.5]4.3 [4.1, 4.5]4.3 [4.1, 4.5]0.25bPreop calcium* (mg/dL)9.6 [9.3, 9.9]9.6 [9.3, 9.9]9.6 [9.3, 9.9]9.6 [9.3, 9.9]0.52bPreop serum creatinine* (mg/dL)0.81 [0.70, 0.94]0.80 [0.70, 0.94]0.81 [0.71, 0.93]0.81 [0.70, 0.95]0.53bPreop iron* (µg/dL)65.0 [51.0, 83.0]66.0 [51.0, 84.0]65.0 [51.0, 84.0]65.0 [51.0, 83.0]0.86bPreop Vitamin D* (ng/mL)24.1 [16.4, 32.5]24.4 [17.2, 32.6]23.8 [15.7, 32.2]24.1 [16.5, 32.6]0.73bPreop Vitamin B12* (pg/mL)504.0 [378.0, 682.0]503.0 [377.0, 679.0]510.0 [379.0, 690.0]502.0 [376.5, 681.5]0.82bArea deprivation Index (ADI)Nationwide ADI Rank71.0 [49.0, 90.0]77.0 [50.0, 92.0]70.0 [50.0, 89.0]70.0 [47.0, 87.0]0.045bstatewide ADI rank6.0 [3.0, 9.0]7.0 [3.0, 9.0]6.0 [3.0, 8.0]6.0 [3.0, 8.0]0.034b30-Day postoperative outcomesDeath12 (0.35)4 (0.44)4 (0.45)4 (0.24)0.60dReadmissions322 (9.4)88 (9.8)93 (10.5)141 (8.6)0.27cReoperations113 (3.3)32 (3.6)28 (3.2)53 (3.2)0.88c*Data not available for all subjects.

Source: Preoperative characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A total of 5097 patients were included in this study cohort, including 3424 patients who underwent RYGB and 1673 who underwent SG.

Source: Abstract.

This is an Institutional Review Board-approved retrospective cohort study in which data were queried from our institutional contributions to the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) to identify patients 18 years or older who underwent sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) within Cleveland Clinic hospitals in Ohio from 2010 to 2018.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between geospatial disparities in food security with weight loss and nutritional outcomes of metabolic surgery

Cohort study · Surgical Endoscopy · 2024

Original publication title

Association between geospatial disparities in food security with weight loss and nutritional outcomes of metabolic surgery

Avia D. Wilkerson; Corey Gentle; Elizabeth N. Dewey; Nitin Sajankila; R. Blake Buchalter; Andrew T. Strong; Xiaoxi Feng; Mary Elizabeth Patti; Sofya Asfaw; Rickesha Wilson; Ali Aminian

© The Author(s) 2024

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Despite the established relationship between food insecurity and obesity, food insecurity does not negatively impact weight loss or nutritional outcomes following RYGB or SG, demonstrating metabolic surgery as a powerful and equitable tool for treating obesity.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Food insecurity has been linked to higher rates of obesity. It has also been shown to diminish the effectiveness of weight loss strategies, including intensive lifestyle interventions. One essential component of food insecurity is having a geospatial disadvantage in access to healthy, affordable food, such as living within a food desert. This study aims to determine if food insecurity also impacts weight loss and nutritional outcomes in patients who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).

Source: Background

Abstract: What methods does the paper describe?

Clinical outcomes of patients who underwent RYGB or SG at Cleveland Clinic or affiliate regional hospitals in the United States from 2010 to 2018 were collected. Modified Retail Food Environmental Index (mRFEI) data was collected from the Center for Disease Control and merged with patient census tract data, allowing the patient cohort to be divided into those living in areas identified as food secure (mRFEI > 10%), food swamps (mRFEI = 1 to 10%), or food deserts (mRFEI = 0). Postoperative weight change was evaluated with quadratic growth mixture models and stratified by surgery type.

Source: Methods

Abstract: Level of Evidence

Abstract: Results

A total of 5097 patients were included in this study cohort, including 3424 patients who underwent RYGB and 1673 who underwent SG. The median duration of follow-up was 2.3 years (IQR 0.89 to 3.6 years). Food security status was not associated with postoperative weight change (RYGB p = 0.73, SG p = 0.60), weight loss nadir (RYGB p = 0.60, SG p = 0.79), or weight regain (RYGB p = 0.93, SG p = 0.85). Deficiencies in nutritional markers at 1 to 2 years after surgery were also not significantly different between food security groups.

Source: Results

Abstract: Conclusion

Despite the established relationship between food insecurity and obesity, food insecurity does not negatively impact weight loss or nutritional outcomes following RYGB or SG, demonstrating metabolic surgery as a powerful and equitable tool for treating obesity.

Source: Conclusion
Authors’ abstract

Background

Food insecurity has been linked to higher rates of obesity. It has also been shown to diminish the effectiveness of weight loss strategies, including intensive lifestyle interventions. One essential component of food insecurity is having a geospatial disadvantage in access to healthy, affordable food, such as living within a food desert. This study aims to determine if food insecurity also impacts weight loss and nutritional outcomes in patients who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).

Methods

Clinical outcomes of patients who underwent RYGB or SG at Cleveland Clinic or affiliate regional hospitals in the United States from 2010 to 2018 were collected. Modified Retail Food Environmental Index (mRFEI) data was collected from the Center for Disease Control and merged with patient census tract data, allowing the patient cohort to be divided into those living in areas identified as food secure (mRFEI > 10%), food swamps (mRFEI = 1 to 10%), or food deserts (mRFEI = 0). Postoperative weight change was evaluated with quadratic growth mixture models and stratified by surgery type.

Results

A total of 5097 patients were included in this study cohort, including 3424 patients who underwent RYGB and 1673 who underwent SG. The median duration of follow-up was 2.3 years (IQR 0.89 to 3.6 years). Food security status was not associated with postoperative weight change (RYGB p = 0.73, SG p = 0.60), weight loss nadir (RYGB p = 0.60, SG p = 0.79), or weight regain (RYGB p = 0.93, SG p = 0.85). Deficiencies in nutritional markers at 1 to 2 years after surgery were also not significantly different between food security groups.

Conclusion

Despite the established relationship between food insecurity and obesity, food insecurity does not negatively impact weight loss or nutritional outcomes following RYGB or SG, demonstrating metabolic surgery as a powerful and equitable tool for treating obesity.

Level of Evidence

IV.

Publication and source details

Original title: Association between geospatial disparities in food security with weight loss and nutritional outcomes of metabolic surgery

Avia D. Wilkerson; Corey Gentle; Elizabeth N. Dewey; Nitin Sajankila; R. Blake Buchalter; Andrew T. Strong; Xiaoxi Feng; Mary Elizabeth Patti; Sofya Asfaw; Rickesha Wilson; Ali Aminian

Surgical Endoscopy · 2024

© The Author(s) 20242024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T09:52:37.192980+00:00

DOI: 10.1007/s00464-024-11175-1 · PMC11525319